2025 Highlights

Montefiore Einstein Comprehensive Cancer Center

For more than 50 years, Montefiore Einstein Comprehensive Cancer Center (MECCC) has been at the forefront of cancer research, care, and community engagement. Our mission is to reduce the cancer burden and provide compassionate cancer care for all, notably in the Bronx. Our unique offerings include access to a broad array of innovative new treatments, Phase I clinical trials with a strong developmental therapeutics program, a renowned cell therapy program, numerous options for minimally invasive/robotic surgeries for most cancer types, state-of-the-art radiation technologies, i.e., proton therapy, and many others, including world-class foundational cancer research programs. We are a leading Center for providing cancer screenings to all eligible patients in the Bronx and expanding access to care utilizing unique tools and artificial intelligence to enhance continuity of care and patient communication. We continue to build upon our exceptional training programs and investments in Survivorship Programs with dedicated clinics across most of our Cancer Center locations.

DATA & STATISTICS

MECCC by the numbers

See how the past few years have been a remarkable time of vision and growth in cancer research and patient care
Explore the numbers
Illustration of man walking up rising bar graph

$7M

in cancer-related research funding

1,572

cancer patients enrolled in clinical research studies

160,000+

outpatient visits

560+

physicians, nurse practitioners, physician assistants, and allied health professionals

Team News

Additions to our distinguished faculty

Alissa C. Baker, MD

Assistant Professor, Department of Pediatrics and Department of Developmental & Molecular Biology
Montefiore Einstein Comprehensive Cancer Center
Albert Einstein College of Medicine
Full Profile

Kartik Chandran, PhD

Professor, Department of Microbiology & Immunology
Gertrude and David Reinson Chair in Medicine
Montefiore Einstein Comprehensive Cancer Center
Albert Einstein College of Medicine
Full Profile

Alana Deutsch, MD

Assistant Professor, Medicine (Dermatology)
Montefiore Einstein Comprehensive Cancer Center
Albert Einstein College of Medicine
Full Profile

Marco A. Fragoso Garcia, PhD

Research Assistant Professor, Department of Pathology
Montefiore Einstein Comprehensive Cancer Center
Albert Einstein College of Medicine
Full Profile

Thomas Hägglöf, PhD

Assistant Professor, Department of Microbiology & Immunology
Montefiore Einstein Comprehensive Cancer Center
Albert Einstein College of Medicine
Full Profile

Richard S. Ha, MD

Professor, Department of Radiology (Breast Imaging)
Vice Chair, Radiology Outpatient Imaging Operations
Chief, Community Radiology, Montefiore Einstein
Montefiore Einstein Comprehensive Cancer Center
Albert Einstein College of Medicine
Full Profile

Hongdau (Peter) Liu, MD, PhD

Assistant Professor, Surgery
Montefiore Einstein Comprehensive Cancer Center
Albert Einstein College of Medicine
Full Profile

Allison M. Martin, MD

Assistant Professor, Pediatrics, Microbiology and Immunology
Attending Physician, Children’s Hospital at Montefiore Einstein
Montefiore Einstein Comprehensive Cancer Center
Albert Einstein College of Medicine
Full Profile

Rachel Offenbacher, MD

Clinical Assistant Professor, Department of Pediatrics (Pediatric Hematology-Oncology)
Attending Physician, Children’s Hospital at Montefiore Einstein
Montefiore Einstein Comprehensive Cancer Center
Albert Einstein College of Medicine
Full Profile

Byun Han Rhieu, MD

Assistant Professor, Radiation Oncology
Montefiore Einstein Comprehensive Cancer Center
Albert Einstein College of Medicine
Full Profile

David E. Schecter, MD

Interventional Pulmonologist
Montefiore Einstein Comprehensive Cancer Center
Full Profile

Patrick F. Timmins, MD

Associate Professor, Department of Obstetrics & Gynecology and Women’s Health
Vice Chair, Legislative Affairs, Albert Einstein College of Medicine
Montefiore Einstein Comprehensive Cancer Center
Albert Einstein College of Medicine
Full Profile

Louis M. Weiss, MD, MPH

Professor, Department of Pathology
Professor, Department of Medicine (Infectious Diseases)
Vice Chair for Academic Affairs and Research, Department of Pathology
Co-Director, Einstein Global Health Center
Montefiore Einstein Comprehensive Cancer Center
Albert Einstein College of Medicine
Full Profile

Clinical Trials

Advancing cancer care through clinical trials

We focus on clinical research studies on all types of cancer in our community. All our patients have access to novel cutting-edge agents, interventions, and preventative approaches through our clinical trials. Cancer Center investigators have been busy developing novel trials through our investigator-initiated trials program and conducting multiple studies, including on agents that have been developed through our robust transdisciplinary research programs, translational accelerator mechanisms, and Shared Resources programming with Albert Einstein College of Medicine laboratories.

Highlights from our current 500 clinical research studies include:

Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer

FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3

A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors

Research Review

Improving cancer care & outcomes through research

We strive to improve cancer care and outcomes through multiple transdisciplinary research programs and initiatives funded by the National Institutes of Health, including the National Cancer Institute, major cancer research foundations, and pharmaceutical companies. Our internationally renowned blood cancer scientists have discovered key drivers of acute myeloid leukemia (AML), breast cancer, and other cancers that arise from abnormal stem cells, which are extremely difficult to eradicate. MECCC is breaking new ground in such areas as cancer dormancy and awakening, stem cells in cancer, disrupted cancer gene regulation and metabolism, correlating environmental exposures to cancer risk and mortality, and understanding the influence of the immune system in shaping the body’s reaction to cancer cells.

Expanding access

Access matters. We are located in the Bronx, the northernmost of the five boroughs that comprise New York City, and we are rapidly expanding the number of locations where people can easily be seen throughout the Tristate area, no matter the level of income, cancer risk, or cancer diagnosis. As of 2025: MECCC has 20 outpatient locations.

View All Cancer Care Locations

Cast your vote

Polls on Doximity close soon. We hope you’ll consider nominating Montefiore Einstein Comprehensive Cancer Center for the U.S. News & World Report Best Hospitals survey.​​​​​​​

 

Contact us

Anne McDarby
Associate Director, Network Program Management
Montefiore Einstein Comprehensive Cancer Center

1-718-862-8840 /ext. 5034
amcdarby@montefiore.org

Andrea Peirce
Assistant Director, Communications
Montefiore Einstein Comprehensive Cancer Center
andrea.peirce@einsteinmed.edu

Montefiore Einstein Comprehensive Cancer Center